Home › Non-Muscle Invasive Bladder Cancer › Maryland
Non-Muscle Invasive Bladder Cancer clinical trials in Maryland
8 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in Maryland.
Cities in Maryland
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- FMH James M Stockman Cancer Institute, Frederick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07000084Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Johns Hopkins University, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06995677A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
- Johns Hopkins University ( Site 0055), Baltimore
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT06637423FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Johns Hopkins Kimmel Cancer Center, Baltimore
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
- Johns Hopkins University (Data Collection Only), Baltimore
RecruitingPhase 3
Ages 21 and older · All sexes · Updated Aug 20, 2026 · NCT06929286LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- John Hopkins Hospital, Baltimore
- Chesapeake Urology Research Associates, Hanover
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- Anna Arundel Urology, Annapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT05710848Blue Light Cystoscopy With Cysview® Registry
- Johns Hopkins Medicine, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT02660645From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.